Mary T Szela - Net Worth and Insider Trading

Mary T Szela Net Worth

The estimated net worth of Mary T Szela is at least $13 Million dollars as of 2024-05-11. Mary T Szela is the Senior Vice President of Abbott Laboratories and owns about 119,422 shares of Abbott Laboratories (ABT) stock worth over $13 Million. Mary T Szela is also the Director of Coherus BioSciences Inc and owns about 0 shares of Coherus BioSciences Inc (CHRS) stock worth over $0. Details can be seen in Mary T Szela's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Mary T Szela has not made any transactions after 2020-06-22 and currently still holds the listed stock(s).

Transaction Summary of Mary T Szela

To

Mary T Szela Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Mary T Szela owns 10 companies in total, including Kura Oncology Inc (KURA) , Coherus BioSciences Inc (CHRS) , and Alimera Sciences Inc (ALIM) among others .

Click here to see the complete history of Mary T Szela’s form 4 insider trades.

Insider Ownership Summary of Mary T Szela

Ticker Comapny Transaction Date Type of Owner
KURA Kura Oncology Inc 2018-11-06 director
CHRS Coherus BioSciences Inc 2020-06-22 director
ALIM Alimera Sciences Inc 2018-06-19 director
2017-05-09 director & Chief Executive Officer
2016-11-29 director & Chief Executive Officer
2011-12-14 Senior Vice President
2021-03-11 director
2021-07-29 director
2023-08-10 director & CEO and President
2023-08-10 director & CEO and President

Mary T Szela Latest Holdings Summary

Mary T Szela currently owns a total of 2 stocks. Among these stocks, Mary T Szela owns 119,422 shares of Abbott Laboratories (ABT) as of December 14, 2011, with a value of $13 Million and a weighting of 100%. Mary T Szela also owns 0 shares of Coherus BioSciences Inc (CHRS) as of June 22, 2020, with a value of $0 and a weighting of 0%.

Latest Holdings of Mary T Szela

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
ABT Abbott Laboratories 2011-12-14 119,422 104.74 12,508,260
CHRS Coherus BioSciences Inc 2020-06-22 0 1.90 0

Holding Weightings of Mary T Szela


Mary T Szela Form 4 Trading Tracker

According to the SEC Form 4 filings, Mary T Szela has made a total of 0 transactions in Abbott Laboratories (ABT) over the past 5 years. The most-recent trade in Abbott Laboratories is the sale of 53,201 shares on December 14, 2011, which brought Mary T Szela around $3 Million.

According to the SEC Form 4 filings, Mary T Szela has made a total of 1 transactions in Coherus BioSciences Inc (CHRS) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Coherus BioSciences Inc is the sale of 54,997 shares on June 22, 2020, which brought Mary T Szela around $966,847.

Insider Trading History of Mary T Szela

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Mary T Szela Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Mary T Szela Ownership Network

Ownership Network List of Mary T Szela

No Data

Ownership Network Relation of Mary T Szela


Mary T Szela Owned Company Details

What does Kura Oncology Inc do?

Who are the key executives at Kura Oncology Inc?

Mary T Szela is the director of Kura Oncology Inc. Other key executives at Kura Oncology Inc include Chief Medical Officer Stephen Dale , SVP & Finance & Accounting Thomas James Doyle , and Chief Operating Officer Kathleen Ford .

Kura Oncology Inc (KURA) Insider Trades Summary

Over the past 18 months, Mary T Szela made no insider transaction in Kura Oncology Inc (KURA). Other recent insider transactions involving Kura Oncology Inc (KURA) include a net sale of 21,208 shares made by Stephen Dale , a net sale of 4,153 shares made by Teresa Brophy Bair , and a net sale of 3,866 shares made by Thomas James Doyle .

In summary, during the past 3 months, insiders sold 0 shares of Kura Oncology Inc (KURA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 125,502 shares of Kura Oncology Inc (KURA) were sold and 50,000 shares were bought by its insiders, resulting in a net sale of 75,502 shares.

Kura Oncology Inc (KURA)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Kura Oncology Inc Insider Transactions

No Available Data

Mary T Szela Mailing Address

Above is the net worth, insider trading, and ownership report for Mary T Szela. You might contact Mary T Szela via mailing address: 10835 Road To The Cure, Suite 205, San Diego Ca 92121.

Discussions on Mary T Szela

No discussions yet.